Clinical trial Recruiting at 3 sites Interventional Ages 18 and up

Physical therapy and NLRP3-related ICU-acquired muscle weakness

Official title: Effect of Physical Therapy on NLRP3 Inflammasome Activation and Muscle Atrophy in Critical Illness Myopathy (PT-NLRP3-CIM).

Run by University of Chile · NCT07017517 · Data updated 2026-11-12

This study will test whether enhanced physical therapy using servo-assisted bed cycling can reduce NLRP3 inflammasome activation and muscle wasting in critically ill patients at risk of critical illness myopathy.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment24 (estimated)
SponsorUniversity of Chile
Academic / other
Drugs / interventionschemotherapy
Locations3 sites (Santiago, Metropolitan Region and 2 other locations)
StatusRecruiting
StartedApril 20, 2026
Main results expectedMay 2027
Study endsMay 2027
Registry record updatedMay 6, 2026
Trial IDNCT07017517 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with sepsis admitted to the ICU who are invasively mechanically ventilated and expected to require ventilation for ≥7 days with sustained high SOFA scores in the early ICU period.

Probably not a fit

Patients with pre-existing neuromuscular disease, severe coagulopathy or thrombocytopenia, imminent death, expected ICU stay under seven days, or other listed exclusions are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized interventional study will assign critically ill, septic patients expected to require prolonged mechanical ventilation to either enhanced physical therapy with Motomed Letto® servo-assisted bed cycling plus standard physiotherapy or to standard physiotherapy alone during the early ICU stay. Researchers will measure markers of NLRP3 inflammasome activation and atrogene expression alongside clinical indicators of muscle degradation and function. The trial focuses on patients with high organ failure scores who are at elevated risk for ICU-acquired weakness, and compares molecular and clinical outcomes between the two physical therapy approaches. The aim is to determine whether early, intensified mobilization reduces inflammatory signaling in skeletal muscle and limits atrophy.

Why it matters

Potential benefit: If successful, the intervention could lessen muscle atrophy, shorten recovery time, and improve functional outcomes after critical illness.

How similar studies have gone: Preclinical animal studies link NLRP3 inflammasome activation to muscle atrophy and show that exercise or early mobilization can reduce inflammasome markers, but direct clinical evidence for servo-assisted cycling reducing NLRP3 activation in ICU patients is limited and relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Medical diagnosis of sepsis upon ICU admission.
* Receiving invasive mechanical ventilation with a projected requirement ≥7 days.
* SOFA score ≥8 for three consecutive days within the first five days of ICU admission.

Exclusion Criteria:

* Neurocritical illness.
* Prior malnutrition or cachexia.
* Pre-existing neuromuscular disease.
* Coagulopathy (severe liver disease or continuous dialysis).
* Thrombocytopenia \<20,000 platelets/μL.
* Prior Clinical Frailty Scale ≥4.
* Lower limb amputation or fractures.
* Ongoing chemotherapy.
* Pregnancy.
* BMI \>35.
* Uncontrolled epilepsy.
* Allergy to ultrasound gel.
* Prior prolonged corticosteroid therapy.
* Expected ICU stay \<7 days.
* Imminent death.
* Legal guardian refusal to provide informed consent.

Where it's running

  • Clínica INDISA
    Santiago, Metropolitan Region, Chile
    Recruiting
  • Hospital de Urgencia Asistencia Pública (HUAP)
    Santiago, Metropolitan Region, Chile
    Recruiting
  • University of Chile
    Santiago, Metropolitan Region, Chile
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.